Multiparametric or practical quantitative liver MRI: towards millisecond, fat fraction, kilopascal and function era

References

• Wieckowska A, McCullough AJ, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology. 2007;46:582–589.
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzen LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–873.
   PubMed Web of Science ®Google Scholar
• Aube C. Imaging modalities for the diagnosis of hepatic fibrosis and cirrhosis. Clin Res Hepatol Gastroenterol. 2015;39:38–44.
   PubMed Web of Science ®Google Scholar
• Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449–1457.
   PubMed Web of Science ®Google Scholar
• Poynard T, Lenaour G, Vaillant JC, et al. Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis. Clin Gastroenterol Hepatol. 2012;10(657–663):e657.
   PubMed Web of Science ®Google Scholar
• Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614–2618.
   PubMed Web of Science ®Google Scholar
• Deng M, Zhao F, Yuan J, et al. Liver T1rho MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence. Br J Radiol. 2012;85:e590–595.
   PubMed Web of Science ®Google Scholar
• Parkes J, Guha IN, Roderick P, et al. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol. 2006;44:462–474.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M, Practice Guidelines Committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236.
   PubMed Web of Science ®Google Scholar
• Friedman SL. Liver fibrosis – from bench to bedside. J Hepatol. 2003;38(Suppl 1):S38–53.
   PubMed Web of Science ®Google Scholar
• Strader DB, Wright T, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39:1147–1171.
   PubMed Web of Science ®Google Scholar
• Casado JL, Quereda C, Moreno A, et al. Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection. J Viral Hepat. 2013;20:829–837.
   PubMed Web of Science ®Google Scholar
• Chang TT, Liaw YF, Wu SS, et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology. 2010;52:886–893.
   PubMed Web of Science ®Google Scholar
• Forns X, Charlton M, Denning J, et al. Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation. Hepatology. 2015;61:1485–1494.
   PubMed Web of Science ®Google Scholar
• Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468–475.
   PubMed Web of Science ®Google Scholar
• Okada M, Murakami T, Yada N, et al. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver. J Magn Reson Imaging. 2015;41:329–338.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Kanematsu M, Goshima S, et al. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging–preliminary observations. Radiology. 2011;259:142–150.
   PubMed Web of Science ®Google Scholar
• Haimerl M, Verloh N, Zeman F, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS One. 2013;8:e85658.
   PubMed Web of Science ®Google Scholar
• Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011;46:277–283.
   PubMed Web of Science ®Google Scholar
• Stanisz GJ, Henkelman RM. Gd-DTPA relaxivity depends on macromolecular content. Magn Reson Med. 2000;44:665–667.
   PubMed Web of Science ®Google Scholar
• Kim KA, Park MS, Kim IS, et al. Quantitative evaluation of liver cirrhosis using T1 relaxation time with 3 tesla MRI before and after oxygen inhalation. J Magn Reson Imaging. 2012;36:405–410.
   PubMed Web of Science ®Google Scholar
• Hoad CL, Palaniyappan N, Kaye P, et al. A study of T(1) relaxation time as a measure of liver fibrosis and the influence of confounding histological factors. NMR Biomed. 2015;28:706–714.
   PubMed Web of Science ®Google Scholar
• Heye T, Yang SR, Bock M, et al. MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis. Eur Radiol. 2012;22:1224–1232.
   PubMed Web of Science ®Google Scholar
• Li Z, Sun J, Hu X, et al. Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. J Magn Reson Imaging. 2016;43:698–703.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Pavlides M, Tunnicliffe EM, et al. Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol. 2014;60:69–77.
   PubMed Web of Science ®Google Scholar
• Pavlides M, Banerjee R, Sellwood J, et al. Multi-parametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol. 2016;64:308–315.
   PubMed Web of Science ®Google Scholar
• Ding Y, Sx R, Chen C, et al. Assessing liver function in patients with HBV-related HCC: a comparison of T(1) mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI. Eur Radiol. 2015;25:1392–1398.
   PubMed Web of Science ®Google Scholar
• Kamimura K, Fukukura Y, Yoneyama T, et al. Quantitative evaluation of liver function with T1 relaxation time index on Gd-EOB-DTPA-enhanced MRI: comparison with signal intensity-based indices. J Magn Reson Imaging. 2014;40:884–889.
   PubMed Web of Science ®Google Scholar
• Ding Y, Rao Sx, Zhu T, et al. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging. Clin Radiol. 2015;70:1096–1103.
   PubMed Web of Science ®Google Scholar
• Besa C, Bane O, Jajamovich G, et al. 3D T1 relaxometry pre and post gadoxetic acid injection for the assessment of liver cirrhosis and liver function. Magn Reson Imaging. 2015;33:1075–1082.
   PubMed Web of Science ®Google Scholar
• Ding Y, Rao Sx, Meng T, Chen C, et al. Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease. Eur Radiol. 2014;24:959–966.
   PubMed Web of Science ®Google Scholar
• Jia J, Keiser M, Nassif A, et al. A LC-MS/MS method to evaluate the hepatic uptake of the liver-specific magnetic resonance imaging contrast agent gadoxetate (Gd-EOB-DTPA) in vitro and in humans. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;891-892:20–26.
   PubMed Web of Science ®Google Scholar
• Nassif A, Jia J, Keiser M, et al. Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging. Radiology. 2012;264:741–750.
   PubMed Web of Science ®Google Scholar
• De Bazelaire CM, Duhamel GD, Rofsky NM, et al. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology. 2004;230:652–659.
   PubMed Web of Science ®Google Scholar
• Zhao F, Deng M, Yuan J, et al. Experimental evaluation of accelerated T1rho relaxation quantification in human liver using limited spin-lock times. Korean J Radiol. 2012;13:736–742.
   PubMed Web of Science ®Google Scholar
• Zhao F, Wang YX, Yuan J, et al. MR T1rho as an imaging biomarker for monitoring liver injury progression and regression: an experimental study in rats with carbon tetrachloride intoxication. Eur Radiol. 2012;22:1709–1716.
   PubMed Web of Science ®Google Scholar
• Yuan J, Zhao F, Griffith JF, et al. Optimized efficient liver T(1rho) mapping using limited spin lock times.. Phys Med Biol. 2012;57:1631–1640.
   PubMed Web of Science ®Google Scholar
• Wang YX, Yuan J, Chu ES, et al. T1rho MR imaging is sensitive to evaluate liver fibrosis: an experimental study in a rat biliary duct ligation model. Radiology. 2011;259:712–719.
   PubMed Web of Science ®Google Scholar
• Rauscher I, Eiber M, Ganter C, et al. Evaluation of T1rho as a potential MR biomarker for liver cirrhosis: comparison of healthy control subjects and patients with liver cirrhosis. Eur J Radiol. 2014;83:900–904.
   PubMed Web of Science ®Google Scholar
• Sirlin CB. Science to practice: can T1rho imaging be used to diagnose and assess the severity of hepatic fibrosis?. Radiology. 2011;259:619–620.
   PubMed Web of Science ®Google Scholar
• Allkemper T, Sagmeister F, Cicinnati V, et al. Evaluation of fibrotic liver disease with whole-liver T1rho MR imaging: a feasibility study at 1.5 T. Radiology. 2014;271:408–415.
   PubMed Web of Science ®Google Scholar
• Takayama Y, Nishie A, Asayama Y, et al. T1 rho relaxation of the liver: a potential biomarker of liver function.. J Magn Reson Imaging. 2015;42:188–195.
   PubMed Web of Science ®Google Scholar
• Singh A, Reddy D, Haris M, et al. T1rho MRI of healthy and fibrotic human livers at 1.5 T. J Transl Med. 2015;13:292
   PubMed Web of Science ®Google Scholar
• Zhao F, Yuan J, Deng M, et al. Further exploration of MRI techniques for liver T1rho quantification. Quant Imaging Med Surg. 2013;3:308–315.
   PubMedGoogle Scholar
• Chen X, Qin L, Pan D, et al. Liver diffusion-weighted MR imaging: reproducibility comparison of ADC measurements obtained with multiple breath-hold, free-breathing, respiratory-triggered, and navigator-triggered techniques. Radiology. 2014;271:113–125.
   PubMed Web of Science ®Google Scholar
• Do RK, Chandarana H, Felker E, et al. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR Am J Roentgenol. 2010;195:671–676.
   PubMed Web of Science ®Google Scholar
• Dyvorne HA, Galea N, Nevers T, et al. Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters–a pilot study. Radiology. 2013;266:920–929.
   PubMed Web of Science ®Google Scholar
• Girometti R, Furlan A, Esposito G, et al. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echo-planar diffusion-weighted sequences. J Magn Reson Imaging. 2008;28:411–419.
   PubMed Web of Science ®Google Scholar
• Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology. 2007;46:658–665.
   PubMed Web of Science ®Google Scholar
• Ragheb H, Thacker NA, Guyader JM, et al. The accuracy of ADC measurements in liver is improved by a tailored and computationally efficient local-rigid registration algorithm. PLoS One. 2015;10:e0132554.
   PubMed Web of Science ®Google Scholar
• Taouli B, Koh DM. Diffusion-weighted MR imaging of the liver. Radiology. 2010;254:47–66.
   PubMed Web of Science ®Google Scholar
• Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol. 2007;189:799–806.
   PubMed Web of Science ®Google Scholar
• Annet L, Peeters F, Abarca-Quinones J, et al. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging. 2007;25:122–128.
   PubMed Web of Science ®Google Scholar
• Bakan AA, Inci E, Bakan S, et al. Utility of diffusion-weighted imaging in the evaluation of liver fibrosis. Eur Radiol. 2012;22:682–687.
   PubMed Web of Science ®Google Scholar
• Bonekamp S, Torbenson MS, Kamel IR. Diffusion-weighted magnetic resonance imaging for the staging of liver fibrosis. J Clin Gastroenterol. 2011;45:885–892.
   PubMed Web of Science ®Google Scholar
• Cece H, Ercan A, Yildiz S, et al. The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis. Eur J Radiol. 2013;82:e307–312.
   PubMed Web of Science ®Google Scholar
• Feier D, Balassy C, Bastati N, et al. The diagnostic efficacy of quantitative liver MR imaging with diffusion-weighted, SWI, and hepato-specific contrast-enhanced sequences in staging liver fibrosis-a multiparametric approach. Eur Radiol. 2016;26:539–546.
   PubMed Web of Science ®Google Scholar
• Fujimoto K, Tonan T, Azuma S, et al. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology. 2011;258:739–748.
   PubMed Web of Science ®Google Scholar
• Girometti R, Furlan A, Bazzocchi M, et al. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med. 2007;112:394–408.
   PubMed Web of Science ®Google Scholar
• Koinuma M, Ohashi I, Hanafusa K, et al. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging. 2005;22:80–85.
   PubMed Web of Science ®Google Scholar
• Peng SS, Jeng YM, Hsu WM, et al. Hepatic ADC map as an adjunct to conventional abdominal MRI to evaluate hepatic fibrotic and clinical cirrhotic severity in biliary atresia patients. Eur Radiol. 2015;25:2992–3002.
   PubMed Web of Science ®Google Scholar
• Sandrasegaran K, Akisik FM, Lin C, et al. Value of diffusion-weighted MRI for assessing liver fibrosis and cirrhosis. AJR Am J Roentgenol. 2009;193:1556–1560.
   PubMed Web of Science ®Google Scholar
• Soylu A, Kilickesmez O, Poturoglu S, et al. Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis. Diagn Interv Radiol. 2010;16:204–208.
   PubMed Web of Science ®Google Scholar
• Taouli B, Chouli M, Martin AJ, et al. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging. 2008;28:89–95.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ganger DR, Levitsky J, et al. Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol. 2011;196:553–561.
   PubMedGoogle Scholar
• Le Bihan D, Breton E, Lallemand D, et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168:497–505.
   PubMed Web of Science ®Google Scholar
• Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging–pilot study. Radiology. 2008;249:891–899.
   PubMed Web of Science ®Google Scholar
• Boulanger Y, Amara M, Lepanto L, et al. Diffusion-weighted MR imaging of the liver of hepatitis C patients. NMR Biomed. 2003;16:132–136.
   PubMed Web of Science ®Google Scholar
• Regini F, Colagrande S, Mazzoni LN, et al. Assessment of liver perfusion by intravoxel incoherent motion (IVIM) magnetic resonance-diffusion-weighted imaging: correlation with phase-contrast portal venous flow measurements. J Comput Assist Tomogr. 2015;39:365–372.
   PubMed Web of Science ®Google Scholar
• Lu PX, Huang H, Yuan J, et al. Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study. PLoS One. 2014;9:e113846.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Lee JM, Baek JH, et al. Evaluation of hepatic fibrosis using intravoxel incoherent motion in diffusion-weighted liver MRI. J Comput Assist Tomogr. 2014;38:110–116.
   PubMed Web of Science ®Google Scholar
• Wu CH, Ho MC, Jeng YM, et al. Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. Eur Radiol. 2015;25:3552–3559.
   PubMed Web of Science ®Google Scholar
• Bulow R, Mensel B, Meffert P, et al. Diffusion-weighted magnetic resonance imaging for staging liver fibrosis is less reliable in the presence of fat and iron. Eur Radiol. 2013;23:1281–1287.
   PubMed Web of Science ®Google Scholar
• Poyraz AK, Onur MR, Kocakoc E, et al. Diffusion-weighted MRI of fatty liver. J Magn Reson Imaging. 2012;35:1108–1111.
   PubMed Web of Science ®Google Scholar
• Hansmann J, Hernando D, Reeder SB. Fat confounds the observed apparent diffusion coefficient in patients with hepatic steatosis. Magn Reson Med. 2013;69:545–552.
   PubMed Web of Science ®Google Scholar
• Leitao HS, Doblas S, d’Assignies G, et al. Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis. Eur Radiol. 2013;23:461–467.
   PubMed Web of Science ®Google Scholar
• Murphy P, Hooker J, Ang B, et al. Associations between histologic features of nonalcoholic fatty liver disease (NAFLD) and quantitative diffusion-weighted MRI measurements in adults. J Magn Reson Imaging. 2015;41:1629–1638.
   PubMed Web of Science ®Google Scholar
• Parente DB, Paiva FF, Oliveira Neto JA, et al. Intravoxel incoherent motion diffusion weighted MR imaging at 3.0 T: assessment of steatohepatitis and fibrosis compared with liver biopsy in type 2 diabetic patients. PLoS One. 2015;10:e0125653.
   PubMed Web of Science ®Google Scholar
• Guiu B, Petit JM, Capitan V, et al. Intravoxel incoherent motion diffusion-weighted imaging in nonalcoholic fatty liver disease: a 3.0-T MR study. Radiology. 2012;265:96–103.
   PubMed Web of Science ®Google Scholar
• Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5(1207–1213):e1202.
   Google Scholar
• Asbach P, Klatt D, Schlosser B, et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology. 2010;257:80–86.
   PubMed Web of Science ®Google Scholar
• Dzyubak B, Glaser K, Yin M, et al. Automated liver stiffness measurements with magnetic resonance elastography. J Magn Reson Imaging. 2013;38:371–379.
   PubMed Web of Science ®Google Scholar
• Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology. 2007;245:458–466.
   PubMed Web of Science ®Google Scholar
• Salameh N, Larrat B, Abarca-Quinones J, et al. Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology. 2009;253:90–97.
   PubMed Web of Science ®Google Scholar
• Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterol. 2008;135:32–40.
   PubMed Web of Science ®Google Scholar
• Venkatesh SK, Wang G, Lim SG, et al. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol. 2014;24:70–78.
   PubMed Web of Science ®Google Scholar
• Ichikawa S, Motosugi U, Morisaka H, et al. MRI-based staging of hepatic fibrosis: comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography. J Magn Reson Imaging. 2015;42:204–210.
   PubMed Web of Science ®Google Scholar
• Sanchez-Conde M, Montes Ramirez ML, Bellon Cano JM, et al. Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus. J Viral Hepat. 2011;18:e278–283.
   PubMed Web of Science ®Google Scholar
• Verveer C, Zondervan Pe, ten Kate Fj, et al. Evaluation of transient elastography for fibrosis assessment compared with large biopsies in chronic hepatitis B and C. Liver Int. 2012;32:622–628.
   PubMed Web of Science ®Google Scholar
• Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54.
   PubMed Web of Science ®Google Scholar
• Sturm N, Marlu A, Arvers P, et al. Comparative assessment of liver fibrosis by computerized morphometry in naive patients with chronic hepatitis B and C. Liver Int. 2013;33:428–438.
   PubMed Web of Science ®Google Scholar
• Boursier J, De Ledinghen V, Sturm N, et al. Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C. J Gastroenterol. 2014;49:527–537.
   PubMed Web of Science ®Google Scholar
• Shi Y, Guo Q, Xia F, et al. MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness?. Radiology. 2014;273:88–98.
   PubMed Web of Science ®Google Scholar
• Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–384.
   PubMed Web of Science ®Google Scholar
• Colli A, Pozzoni P, Berzuini A, et al. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology. 2010;257:872–878.
   PubMed Web of Science ®Google Scholar
• Huang SY, Abdelsalam ME, Harmoush S, et al. Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis. J Magn Reson Imaging. 2014;39:590–597.
   PubMed Web of Science ®Google Scholar
• Ichikawa S, Motosugi U, Nakazawa T, et al. Hepatitis activity should be considered a confounder of liver stiffness measured with MR elastography. J Magn Reson Imaging. 2015;41:1203–1208.
   PubMed Web of Science ®Google Scholar
• Millonig G, Friedrich S, Adolf S, et al. Liver stiffness is directly influenced by central venous pressure. J Hepatol. 2010;52:206–210.
   PubMed Web of Science ®Google Scholar
• Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592–595.
   PubMed Web of Science ®Google Scholar
• Ronot M, Lambert S, Elkrief L, et al. Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol. 2014;24:1394–1402.
   PubMed Web of Science ®Google Scholar
• Chen J, Talwalkar JA, Yin M, et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology. 2011;259:749–756.
   PubMed Web of Science ®Google Scholar
• Kim D, Kim WR, Talwalkar JA, et al. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. 2013;268:411–419.
   PubMed Web of Science ®Google Scholar
• Loomba R, Wolfson T, Ang B, et al. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology. 2014;60:1920–1928.
   PubMed Web of Science ®Google Scholar
• Yin M, Glaser KJ, Talwalkar JA, et al. Hepatic MR elastography: clinical performance in a series of 1377 consecutive examinations. Radiology. 2016;278:114–124.
   PubMed Web of Science ®Google Scholar
• Roulot D, Czernichow S, Le Clesiau H, et al. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol. 2008;48:606–613.
   PubMed Web of Science ®Google Scholar
• Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828–835.
   PubMed Web of Science ®Google Scholar
• Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18:411–412.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Lee JM, Suh KS, et al. Combined use of MR fat quantification and MR elastography in living liver donors: can it reduce the need for preoperative liver biopsy? Radiology. 2015;276:453–464.
   PubMed Web of Science ®Google Scholar
• Loomba R, Cui J, Wolfson T, et al. Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD: a prospective study. Am J Gastroenterol. 2016;111:986–994.
   PubMed Web of Science ®Google Scholar
• Shin SU, Lee JM, Yu MH, et al. Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique. Radiology. 2014;272:143–153.
   PubMed Web of Science ®Google Scholar
• Hirooka M, Koizumi Y, Hiasa Y, et al. Hepatic elasticity in patients with ascites: evaluation with real-time tissue elastography. AJR Am J Roentgenol. 2011;196:W766–771.
   PubMed Web of Science ®Google Scholar
• Koizumi Y, Hirooka M, Kisaka Y, et al. Liver fibrosis in patients with chronic hepatitis C: noninvasive diagnosis by means of real-time tissue elastography–establishment of the method for measurement. Radiology. 2011;258:610–617.
   PubMed Web of Science ®Google Scholar
• Tatsumi C, Kudo M, Ueshima K, et al. Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan) and real-time tissue elastography. Intervirology. 2008;51(Suppl 1):27–33.
   PubMed Web of Science ®Google Scholar
• Mannelli L, Wilson GJ, Dubinsky TJ, et al. Assessment of the liver strain among cirrhotic and normal livers using tagged MRI. J Magn Reson Imaging. 2012;36:1490–1495.
   PubMed Web of Science ®Google Scholar
• Chung S, Breton E, Mannelli L, et al. Liver stiffness assessment by tagged MRI of cardiac-induced liver motion. Magn Reson Med. 2011;65:949–955.
   PubMed Web of Science ®Google Scholar
• Chung S, Kim KE, Park MS, et al. Liver stiffness assessment with tagged MRI of cardiac-induced liver motion in cirrhosis patients. J Magn Reson Imaging. 2014;39:1301–1307.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Kanematsu M, Kitagawa T, et al. MR elastography of the liver at 3 T with cine-tagging and bending energy analysis: preliminary results. Eur Radiol. 2010;20:2381–2389.
   PubMed Web of Science ®Google Scholar
• Bohte AE, De Niet A, Jansen L, et al. Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C. Eur Radiol. 2014;24:638–648.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Lee JM, Joo I, et al. Hepatic fibrosis: prospective comparison of MR elastography and US shear-wave elastography for evaluation. Radiology. 2014;273:772–782.
   PubMed Web of Science ®Google Scholar
• Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189–194.
   PubMed Web of Science ®Google Scholar
• Hines CD, Frydrychowicz A, Hamilton G, et al. T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis. J Magn Reson Imaging. 2011;33:873–881.
   PubMed Web of Science ®Google Scholar
• Meisamy S, Hines CD, Hamilton G, et al. Quantification of hepatic steatosis with T1-independent, T2-corrected MR imaging with spectral modeling of fat: blinded comparison with MR spectroscopy. Radiology. 2011;258:767–775.
   PubMed Web of Science ®Google Scholar
• Kim H, Taksali SE, Dufour S, et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med. 2008;59:521–527.
   PubMed Web of Science ®Google Scholar
• Permutt Z, Le TA, Peterson MR, et al. Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther. 2012;36:22–29.
   PubMed Web of Science ®Google Scholar
• Tang A, Tan J, Sun M, et al. Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology. 2013;267:422–431.
   PubMed Web of Science ®Google Scholar
• Tang A, Desai A, Hamilton G, et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology. 2015;274:416–425.
   PubMed Web of Science ®Google Scholar
• Idilman IS, Aniktar H, Idilman R, et al. Hepatic steatosis: quantification by proton density fat fraction with MR imaging versus liver biopsy. Radiology. 2013;267:767–775.
   PubMed Web of Science ®Google Scholar
• Paparo F, Cenderello G, Revelli M, et al. Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis. Biomed Res Int. 2015;2015:758164
   PubMed Web of Science ®Google Scholar
• Idilman IS, Keskin O, Celik A, et al. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol. 2016;57:271–278.
   PubMed Web of Science ®Google Scholar
• Idilman IS, Keskin O, Elhan AH, et al. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. Scand J Gastroenterol. 2014;49:617–624.
   PubMed Web of Science ®Google Scholar
• Li TQ, Aisen AM, Hindmarsh T. Assessment of hepatic iron content using magnetic resonance imaging. Acta Radiol. 2004;45:119–129.
   PubMed Web of Science ®Google Scholar
• Gandon Y, Olivie D, Guyader D, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004;363:357–362.
   PubMed Web of Science ®Google Scholar
• Schwenzer NF, Machann J, Haap MM, et al. T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritin. Invest Radiol. 2008;43:854–860.
   PubMed Web of Science ®Google Scholar
• Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–2179.
   PubMed Web of Science ®Google Scholar
• Maris TG, Papakonstantinou O, Chatzimanoli V, et al. Myocardial and liver iron status using a fast T*2 quantitative MRI (T*2qMRI) technique. Magn Reson Med. 2007;57:742–753.
   PubMed Web of Science ®Google Scholar
• St Pierre TG, Clark PR, Chua-Anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105:855–861.
   PubMed Web of Science ®Google Scholar
• Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106:1460–1465.
   PubMed Web of Science ®Google Scholar
• Galimberti S, Trombini P, Bernasconi DP, et al. Simultaneous liver iron and fat measures by magnetic resonance imaging in patients with hyperferritinemia. Scand J Gastroenterol. 2015;50:429–438.
   PubMed Web of Science ®Google Scholar
• Storey P, Thompson AA, Carqueville CL, et al. R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging. 2007;25:540–547.
   PubMed Web of Science ®Google Scholar
• Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol. 2007;14:183–190.
   PubMed Web of Science ®Google Scholar
• Wood JC, Ghugre N. Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases. Hemoglobin. 2008;32:85–96.
   PubMed Web of Science ®Google Scholar
• Karcaaltincaba M, Idilman I, Celik A. Focal sparing of iron and fat in liver tissue in patients with hemosiderosis: diagnosis with combination of R2* relaxometry and proton density fat fraction calculation by MRI. Diagn Interv Radiol. 2011;17:323–327.
   PubMed Web of Science ®Google Scholar
• Ma D, Gulani V, Seiberlich N, et al. Magnetic resonance fingerprinting. Nature. 2013;495:187–192.
   PubMed Web of Science ®Google Scholar
• Pierre EY, Ma D, Chen Y, et al. Multiscale reconstruction for MR fingerprinting. Magn Reson Med. 2016;75:2481–2492.
   PubMed Web of Science ®Google Scholar
• Warntjes JB, Dahlqvist O, Lundberg P. Novel method for rapid, simultaneous T1, T2*, and proton density quantification. Magn Reson Med. 2007;57:528–537.
   PubMed Web of Science ®Google Scholar
• Chen Y, Jiang Y, Pahwa S, et al. MR fingerprinting for rapid quantitative abdominal imaging. Radiology. 2016;279:278–286.
   PubMed Web of Science ®Google Scholar
• Farrar Ct, DePeralta Dk, Day H, et al. 3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model. J Hepatol. 2015;63:689–696.
   PubMed Web of Science ®Google Scholar
• Polasek M, Fuchs BC, Uppal R, et al. Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models. J Hepatol. 2012;57:549–555.
   PubMed Web of Science ®Google Scholar
• Bonny C, Rayssiguier R, Ughetto S, et al. Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region. Gastroenterol Clin Biol. 2003;27:1021–1025.
   PubMedGoogle Scholar
• Siddique I, El-Naga HA, Madda JP, et al. Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C virus infection. Scand J Gastroenterol. 2003;38:427–432.
   PubMed Web of Science ®Google Scholar
• Faria SC, Ganesan K, Mwangi I, et al. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009;29:1615–1635.
   PubMed Web of Science ®Google Scholar
• Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408.
   PubMed Web of Science ®Google Scholar